Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that predispose the brain to synaptic dysfunction and proteinopathy (neurodegenerative diseases characterized by the abnormal folding, aggregation, and accumulation of specific proteins within neurons or brain tissues).